# Canada's $127M Bioprinting Bet Has Novo Nordisk in Fine Print - Date: 2026-04-03 - Category: Biotech & Life Sciences Canada handed $127M to a Vancouver biotech. What the press release did not say: Novo Nordisk transferred its own technology back to that company, leaving Canadian taxpayers to fund the manufacturing infrastructure a global pharma giant decided was too risky to build itself. ---